 Pediatric Kidney Program
Location:
Rm FE009
840 Sherbrook Street
Winnipeg, MB R3A 1S1
Phone (204) 787-4947
Office Hours: M-F 9 am-4 pm
Collaborative Family-Centred Care
Transplant Manitoba-Pediatric Kidney Program takes a holistic approach to pediatric patients with end-stage renal disease, with an emphasis on family-centered care. Comprehensive pre- and post-transplant care is provided by a team of experienced specialists.
Our Vision
Leadership in pediatric kidney transplantation
Our Mission
To provide state of the art, comprehensive, family-centered care to children and families requiring a kidney transplant at Children’s Hospital, Health Sciences Centre Winnipeg.
Our Purpose
We are a group of transplant professionals dedicated to leading, advancing, and advocating for patient care, research and education to improve kidney transplantation for children.
Our Values
Excellence
In all aspects of care delivery from pre-transplant assessment to transplant, post transplant care and transition to the Adult Transplant Service. We promote excellence in patient outcomes for transplant in the Pediatric Kidney Program.
Innovation
In program development, research and care provision in pediatric kidney transplantation.
Accountability
To children and their families, the Pediatric Kidney Program, and the global transplant community for the care we promote and deliver.
Respect
For individual choice, family decisions, cultural values, and team involvement in all communications, interactions and processes.
Quality
In transplant assessment processes, care provided during and after transplant, educational materials and communications.
Communication
With children, families and other professionals in a timely and respectful manner to ensure accuracy, involvement and understanding.
Integrity
Acting on the highest standards of ethical practice in all aspects of individual and organizational functioning.
Collaboration
With children, families and other professionals in a timely and respectful manner to ensure quality care.
Research
In basic science, clinical and social science research to improve the understanding of outcomes related to pediatric kidney transplantation and the care provided to children and families requiring kidney transplant.
Program Team Members
| Medical Director |
Dr. Patricia Birk, MD, FRCP(C) |
Transplant Physician |
Section Head
(Pediatric Nephrology) |
Dr. Tom Blydt-Hansen, MD, FRCP(C), FAAP |
Transplant Physician |
| |
Dr. Aviva Goldberg, MD, FRCP(C) |
Transplant Physician, Bioethicist |
| |
Dr. Kristen Pederson, MD, FRCP(C) |
Dialysis Physician |
| |
Dr Allison Dart, MD, FRCP(C) |
Dialysis Physician |
| |
Dr.Joshua Koulack, MD, FRCP(C) |
Transplant Surgeon |
| |
Dr. Karen Psooy, MD, FRCS(C) |
Urologist |
| |
Dr. Nafisa Dharamsi, MD, FRCS(C) |
Urologist |
| |
Diane McKenty , RN, |
Transplant Nurse Clinician |
| |
Sandy Neustaedter, RN |
Dialysis Nurse Clinician |
| |
Julie Strong, RN, BN |
Pediatric Kidney Transplant Coordinator (Recipient) |
| |
Leslie Irvine, BA(Hons), BSW, RSW |
Social Worker |
| |
Lisa Wilson |
Dietitian |
| |
Dr. Eric Sigurdson |
Renal-Psychiatry Team |
| |
Julie Pannell, RPN, RN |
Renal-Psychiatry Team |
| |
Melodie McCormick |
Administration and
Support Staff |
| |
Gail Martin |
Administration and
Support Staff |
| |
Jody Sawatzky |
Adult Transplant Coordinator (Donor) |
| |
Nancy Dodd |
Process Engineer |
|
From Bench to Bedside:
Transplant Manitoba-Pediatric Kidney Program serves the provinces of Manitoba, Saskatchewan, North Western Ontario and Nunavut. Our program is recognized both nationally and internationally for its innovative clinical research. Cutting-edge research sets the standard for advances in the clinical care of transplanted children. Our unique innovations include:
1. Pediatric Protocol Biopsy and Follow-Up Biopsy Programs for the early detection of subclinical (aka "silent") rejection.
2.Quantitative image analysis to monitor the progression of chronic allograft nephropathy (CAN) (aka "scarring), the leading cause of long-term graft loss in children.
3. Non-invasive biomarkers of rejection using urine nuclear magnetic resonance (NMR).
4. Clincal trials aimed at the modulation of CAN.
Links:
|
